The Bottom Line Retatrutide dosing follows a straightforward 12-week titration: 2 mg for four weeks, 4 mg for four weeks, 8 mg for four weeks, then 12 mg maintenance
While semaglutide will remain under patent in many regions until the early 2030s, the first generic versions are expected to launch in India imminently, with additional market entries anticipated in China, Canada, Brazil, Turkey, and South Africa in the months that follow
2018;363:k3252 Grech O, Clouter A, Mitchell JL, Alimajstorovic Z, Ottridge RS, Yiangou A, et al
Bottom line While feeling cold is not an official side effect of semaglutide, it can happen to some people as their bodies adjust to a lower caloric intake and weight loss on the medication
Non-injectable forms remain available